330 related articles for article (PubMed ID: 23070008)
1. Sphingolipids in apoptosis.
Tirodkar TS; Voelkel-Johnson C
Exp Oncol; 2012 Oct; 34(3):231-42. PubMed ID: 23070008
[TBL] [Abstract][Full Text] [Related]
2. Sphingolipids in mitochondria.
Hernández-Corbacho MJ; Salama MF; Canals D; Senkal CE; Obeid LM
Biochim Biophys Acta Mol Cell Biol Lipids; 2017 Jan; 1862(1):56-68. PubMed ID: 27697478
[TBL] [Abstract][Full Text] [Related]
3. Sphingolipids and mitochondrial apoptosis.
Patwardhan GA; Beverly LJ; Siskind LJ
J Bioenerg Biomembr; 2016 Apr; 48(2):153-68. PubMed ID: 25620271
[TBL] [Abstract][Full Text] [Related]
4. Cancer and sphingolipid storage disease therapy using novel synthetic analogs of sphingolipids.
Gatt S; Dagan A
Chem Phys Lipids; 2012 May; 165(4):462-74. PubMed ID: 22387097
[TBL] [Abstract][Full Text] [Related]
5. [Ca2+ and sphingolipids as modulators for apoptosis and cancer].
Pimentel AA; Benaim G
Invest Clin; 2012 Mar; 53(1):84-110. PubMed ID: 22524111
[TBL] [Abstract][Full Text] [Related]
6. Therapeutic applications of bioactive sphingolipids in hematological malignancies.
Ekiz HA; Baran Y
Int J Cancer; 2010 Oct; 127(7):1497-506. PubMed ID: 20503271
[TBL] [Abstract][Full Text] [Related]
7. The role of ceramide in regulating endoplasmic reticulum function.
Zelnik ID; Ventura AE; Kim JL; Silva LC; Futerman AH
Biochim Biophys Acta Mol Cell Biol Lipids; 2020 Jan; 1865(1):158489. PubMed ID: 31233888
[TBL] [Abstract][Full Text] [Related]
8. Sphingolipids in cancer: regulation of pathogenesis and therapy.
Ogretmen B
FEBS Lett; 2006 Oct; 580(23):5467-76. PubMed ID: 16970943
[TBL] [Abstract][Full Text] [Related]
9. Perturbation of sphingolipid metabolism induces endoplasmic reticulum stress-mediated mitochondrial apoptosis in budding yeast.
Kajiwara K; Muneoka T; Watanabe Y; Karashima T; Kitagaki H; Funato K
Mol Microbiol; 2012 Dec; 86(5):1246-61. PubMed ID: 23062268
[TBL] [Abstract][Full Text] [Related]
10. Sphingolipids and cell death.
Morales A; Lee H; Goñi FM; Kolesnick R; Fernandez-Checa JC
Apoptosis; 2007 May; 12(5):923-39. PubMed ID: 17294080
[TBL] [Abstract][Full Text] [Related]
11. Sphingolipids--the enigmatic lipid class: biochemistry, physiology, and pathophysiology.
Merrill AH; Schmelz EM; Dillehay DL; Spiegel S; Shayman JA; Schroeder JJ; Riley RT; Voss KA; Wang E
Toxicol Appl Pharmacol; 1997 Jan; 142(1):208-25. PubMed ID: 9007051
[TBL] [Abstract][Full Text] [Related]
12. Molecular facets of sphingolipids: mediators of diseases.
Ozbayraktar FB; Ulgen KO
Biotechnol J; 2009 Jul; 4(7):1028-41. PubMed ID: 19579220
[TBL] [Abstract][Full Text] [Related]
13. Ceramide and other sphingolipids in cellular responses.
Yang J; Yu Y; Sun S; Duerksen-Hughes PJ
Cell Biochem Biophys; 2004; 40(3):323-50. PubMed ID: 15211031
[TBL] [Abstract][Full Text] [Related]
14. Ceramide Metabolism Balance, a Multifaceted Factor in Critical Steps of Breast Cancer Development.
García-González V; Díaz-Villanueva JF; Galindo-Hernández O; Martínez-Navarro I; Hurtado-Ureta G; Pérez-Arias AA
Int J Mol Sci; 2018 Aug; 19(9):. PubMed ID: 30149660
[TBL] [Abstract][Full Text] [Related]
15. Ceramide and apoptosis: exploring the enigmatic connections between sphingolipid metabolism and programmed cell death.
Mullen TD; Obeid LM
Anticancer Agents Med Chem; 2012 May; 12(4):340-63. PubMed ID: 21707511
[TBL] [Abstract][Full Text] [Related]
16. Sphingolipid homeostasis in the endoplasmic reticulum and beyond.
Breslow DK
Cold Spring Harb Perspect Biol; 2013 Apr; 5(4):a013326. PubMed ID: 23545423
[TBL] [Abstract][Full Text] [Related]
17. Ceramide in chemotherapy of tumors.
Dimanche-Boitrel MT; Rebillard A; Gulbins E
Recent Pat Anticancer Drug Discov; 2011 Sep; 6(3):284-93. PubMed ID: 21762073
[TBL] [Abstract][Full Text] [Related]
18. Sphingomyelin synthase-related protein SMSr is a suppressor of ceramide-induced mitochondrial apoptosis.
Tafesse FG; Vacaru AM; Bosma EF; Hermansson M; Jain A; Hilderink A; Somerharju P; Holthuis JC
J Cell Sci; 2014 Jan; 127(Pt 2):445-54. PubMed ID: 24259670
[TBL] [Abstract][Full Text] [Related]
19. [Sphingolipid-mediated apoptotic signaling pathways].
Cuvillier O; Andrieu-Abadie N; Ségui B; Malagarie-Cazenave S; Tardy C; Bonhoure E; Levade T
J Soc Biol; 2003; 197(3):217-21. PubMed ID: 14708343
[TBL] [Abstract][Full Text] [Related]
20. Loss of sphingosine kinase-1 activates the intrinsic pathway of programmed cell death: modulation of sphingolipid levels and the induction of apoptosis.
Taha TA; Kitatani K; El-Alwani M; Bielawski J; Hannun YA; Obeid LM
FASEB J; 2006 Mar; 20(3):482-4. PubMed ID: 16507765
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
